Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder

被引：0
|
作者：
Van Baardewijk, M
Vis, PM
Einarson, T
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Toronto, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67791-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A209 / A210
页数：2
相关论文
共 50 条
  • [1] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
    van Baardewijk, M
    Vis, PMJ
    Einarson, TR
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1271 - 1279
  • [2] Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: A meta-analysis of randomized clinical trials
    Vis, PMJ
    van Baardewijk, M
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) : 1798 - 1807
  • [3] A COST-UTILTY ANALYSIS OF VENLAFAXINE XR COMPARED WITH DULOXETINE AND SSRIS FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN ITALY
    Graham, C.
    Narula, H.
    Liu, L. Z.
    Keohane, D.
    Di Virgilio, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [4] Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder
    Nierenberg, Andrew A.
    Trivedi, Madhukar H.
    Gaynes, Bradley N.
    Mitchell, Jeff
    Davis, Lori L.
    Husain, Mustafa M.
    Wisniewski, Stephen R.
    Fava, Maurizio
    Warden, Diane
    Luther, James F.
    van Nieuwenhuizen, Adrienne O.
    Morris, David W.
    Shelton, Richard C.
    Rush, A. John
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 (10): : 956 - 967
  • [5] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
    Fernandez, JL
    Montgomery, S
    Francois, C
    PHARMACOECONOMICS, 2005, 23 (02) : 155 - 167
  • [6] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
    José-Luis Fernandez
    Stuart Montgomery
    Clément Francois
    PharmacoEconomics, 2005, 23 : 155 - 167
  • [7] Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder
    Xie, Feng
    Despiegel, Nicolas
    Danchenko, Natalya
    Hansen, Karina
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (01) : 59 - 69
  • [8] Cost-effectiveness of duloxetine vs. venlafaxine XR and SSRIS in patients with major depressive disorder in primary and secondary care in Spain
    De Cock, E.
    Benedict, A.
    Le, T. K.
    Sacristin del Castillo, J. A.
    Dilla, T.
    VALUE IN HEALTH, 2007, 10 (06) : A295 - A296
  • [9] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [10] Escitalopram vs venlafaxine XR treatment of major depressive disorder
    Montgomery, SA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S207 - S207
12345